Brief: Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance
18/12/2025 14:44
Dec 18 (Reuters) - Abbott Laboratories ABT.N: ABBOTT'S AMPLATZER PICCOLO™ DELIVERY SYSTEM RECEIVES FDA CLEARANCE AND CE MARK TO OPTIMIZE PROCEDURES FOR PREMATURE BABIES WITH A HOLE IN THE HEART Source text: ID:nPn49tvJma Further company coverage: ABT.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbott Laboratories
See all newsBrief: FDA Approves Abbott HIV Combo Next Assay
Press Digest: Wall Street Journal - June 29
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports (updated)
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports
Factbox: Major deals involving US drugmakers and biotechs over the past decade